Lung cancer: Difference between revisions

Latest revision as of 11:56, 1 July 2010

This page is a knowledge crystal of subtype variable. The page identifier is Op_en4536
Moderator:Teemu R (see all)

Upload data {{#opasnet_base_link:Op_en4536}}	{{#opasnet_base_link:Op_en4536}}
This page is a part of Heimtsa incidence database.

Scope

What is the incidence of lung cancer in the general population?

Definition

Rate (age, sex ratio)

Context (population size studied, location, date data taken, end-point measured)

Definition of end-point

Reference

375,000 cases (estimate)
303,000 in men
72,000 in women
Estimated number of resulting deaths = 347,000 (280,000 in men and 67,000 in women).

Estimates of lung-cancer incidence in Europe, 2000
	Men				Women
Country	Crude rate	ASR	Cumulative risk*	No of cases	Crude rate	ASR	Cumulative risk*	No of cases
Eastern Europe	87.2	69•7	4•4	126 653	79•2	63•1	3•8	115 091
Northern Europe	73.5	44•3	1•9	33 976	75•7	45•1	1•8	35 007
Southern Europe	95.9	58•8	3•2	67 518	84•4	50•4	2•5	59 426
Western Europe	83.9	53•2	2•9	75 350	79•1	48•9	2•3	71 024
*Cumulative risks are for ages 0–64 years. ASR, age-standardised rate.

Europe, 2000

^[1]

Relative risk of lung cancer in European men and women
	Men		Women
	Squamous-cell and small-cell carcinoma	Adenocarcinoma	Squamous-cell and small-cell carcinoma	Adenocarcinoma
Non-smoker	1•0	1•0	1•0	1•0
Ex-smoker	16•2*	3•5*	3•8*	1•1
Current smoker	57•9*	8•0*	18•2*	4•1*
* p<0•05

Table 2. Effects of smoking cessation on lung-cancer risk
	Relative risk
Time since stopping	Men	Women
Current smokers	1•00	1•00
2–9 years	0•66*	0•41*
10–19 years	0•27*	0•19*
20–29 years	0•17*	0•08*
>30 years	0•08*	0•13*
Non-smokers	0•04*	0•11*
* p<0•05

n=7,609 with 10,431 controls, 10 case-control studies of lung cancer in 6 countries from 1988 to 1994: Sweden, Germany, United Kingdom, France, Spain, Italy. Lung cancer

^[2]

Number of new cases and rates of lung cancer, UK, 2006
	England		Wales		Scotland		N.Ireland		UK
Cases
Males	18,026		1,299		2,509		547		22,381
Females	13,141		984		2,177		344		16,646
Persons	31,167		2,283		4,686		891		39,027
Crude rate per 100,000 population
Males	72.3		89.9		101.6		64.1		75.4
Females	50.9		64.7		82.2		38.7		53.9
Persons	61.4		77.0		91.6		51.2		64.4
Age-standardised rate (European) per 100,000 population
Males	58.3		65.8		81.7		60.8		60.8
95% CI	57.5	59.2	62.2	69.4	78.5	84.9	55.7	65.9	60.0	61.5
Females	35.0		40.9		55.1		31.5		37.1
95% CI	34.4	35.6	38.3	43.4	52.8	57.4	28.2	34.9	36.5	37.6
Persons	45.2		51.9		66.2		44.3		47.4
95% CI	44.7	45.7	49.8	54.0	64.3	68.1	41.4	47.2	46.9	47.9

UK, 2006, lunch cancer

Doctor diagnosed

^[3]

	INCIDENCE				MORTALITY
	MALE		FEMALE		MALE		FEMALE
	ASR	Cumulative risk	ASR	Cumulative risk	ASR	Cumulative risk	ASR	Cumulative risk
	(World)	(age 0–64)	(World)	(age 0-64)	(World)	(age 0–64)	(World)	(age 0-64)
E. Europe	257.7	14.1	175.1	10.8	197.2	10.4	101.9	5.6
N. Europe	283.1	11.7	252.3	14.0	161.0	5.8	118.1	5.2
S. Europe	299.4	14.2	208.1	12.0	170.1	7.1	92.2	4.2
W. Europe	326.4	15.5	244.6	14.1	173.9	7.0	106.1	4.6
World	209.6	10.3	161.5	9.5	137.7	6.4	92.1	4.9

Worldwide, 1993-2001 with population estimates from 2002 to estimate 2002 cancer burden, from GLOBOCAN database, lung cancer

^[4]

Total prevalence by country and age class. Proportions per 100000 persons
	Men				Women
	0-44	45-64	65+	All ages	0-44	45-64	65+	All ages
Netherlands	3.3	276.5	1468.0	197.4	3.1	79.3	101.1	33.1
Germany	5.6	246.5	907.4	168.0	2.3	51.3	100.1	33.1
Austria	5.7	201.5	610.0	103.1	3.9	68.9	111.1	33.9
Switzerland	6.4	215.0	721.6	145.8	3.4	71.6	144.0	45.9
Slovenia	7.5	262.1	672.0	118.9	1.5	36.1	60.5	17.8
Slovakia	6.3	398.6	1390.4	206.5	2.0	40.3	141.5	28.1
Poland	5.5	216.2	424.5	100.0	2.9	57.3	103.9	32.6
All Euro countries (n=17)	3.8	201.5	791.5	144.1	2.2	59.7	166.1	44.2

Austria, Germany, The Netherlands, Poland, Slovakia, Slovenia and Switzerland, 1970-1992, lung cancer

^[5]

Result

Related files

References

↑ J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55.
↑ Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87.
↑ http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm
↑ D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108
↑ J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh & M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322.

[1] J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55.

[2] Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87.

[3] ttp://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm

[4] D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108

[5] J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh & M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322.

[1]

[2]

[3]

[4]

[5]

@@ Line 74: / Line 74: @@
 | Europe, 2000
 |
-| J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55.
+| <ref>J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55.</ref>
 |----
 |
@@ Line 149: / Line 149: @@
 | n=7,609 with 10,431 controls, 10 case-control studies of lung cancer in 6 countries from 1988 to 1994: Sweden, Germany, United Kingdom, France, Spain, Italy. Lung cancer
 |
-| Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87.
+| <ref>Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87.</ref>
 |----
 |
@@ Line 270: / Line 270: @@
 | UK, 2006, lunch cancer
 | Doctor diagnosed
-| http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm
+| <ref>http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm</ref>
 |----
 |
@@ Line 354: / Line 354: @@
 | Worldwide, 1993-2001 with population estimates from 2002 to estimate 2002 cancer burden, from GLOBOCAN database, lung cancer
 |
-| D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108
+| <ref>D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108</ref>
 |----
 |
@@ Line 456: / Line 456: @@
 | Austria, Germany, The Netherlands, Poland, Slovakia, Slovenia and Switzerland, 1970-1992, lung cancer
 |
-| J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh &amp; M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322.
+| <ref>J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh &amp; M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322.</ref>
 |----
 |}